Downregulation of tyrosine hydroxylase phenotype after AAV injection above substantia nigra: Caution in experimental models of Parkinson's disease-Reference-Cited by-同舟云学术

Downregulation of tyrosine hydroxylase phenotype after AAV injection above substantia nigra: Caution in experimental models of Parkinson's disease

Published:2018-12-12 Issue: Volume: Page:
ISSN:0360-4012
Container-title:Journal of Neuroscience Research
language:en
Short-container-title:J Neuro Res

Author:

Albert Katrina¹^ORCID,Voutilainen Merja H.¹,Domanskyi Andrii¹,Piepponen T. Petteri²,Ahola Sari¹,Tuominen Raimo K.²,Richie Christopher³,Harvey Brandon K.³,Airavaara Mikko¹^ORCID

Affiliation:

1. Institute of Biotechnology, Program of Developmental BiologyUniversity of Helsinki Helsinki Finland

2. Division of Pharmacology and PharmacotherapyUniversity of Helsinki Helsinki Finland

3. Intramural Research ProgramNational Institute on Drug Abuse, NIH Baltimore Maryland

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jnr.24363

Reference60 articles.

1. In heterozygous GDNF knockout mice the response of striatal dopaminergic system to acute morphine is altered

2. AAV vector‐mediated gene delivery to substantia nigra dopamine neurons: Implications for gene therapy and disease models;Albert K.;Genes,2017

3. AAV vector-mediated secretion of chondroitinase provides a sensitive tracer for axonal arborisations

4. Parkinson's disease-like burst firing activity in subthalamic nucleus induced by AAV-α-synuclein is normalized by LRRK2 modulation

5. High correlation between in vivo [123I]β-CIT SPECT/CT imaging and post-mortem immunohistochemical findings in the evaluation of lesions induced by 6-OHDA in rats

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nonpeptidic Oxazole-Based Prolyl Oligopeptidase Ligands with Disease-Modifying Effects on α-Synuclein Mouse Models of Parkinson’s Disease;Journal of Medicinal Chemistry;2023-05-29

2. Protective mechanisms by glial cell line-derived neurotrophic factor and cerebral dopamine neurotrophic factor against the α-synuclein accumulation in Parkinson's disease;Biochemical Society Transactions;2023-02-16

3. Deletion of RE1‐silencing transcription factor in striatal astrocytes exacerbates manganese‐induced neurotoxicity in mice;Glia;2022-05-31

4. Sequential or Simultaneous Injection of Preformed Fibrils and AAV Overexpression of Alpha-Synuclein Are Equipotent in Producing Relevant Pathology and Behavioral Deficits;Journal of Parkinson's Disease;2022-05-24

5. Vocal changes in a zebra finch model of Parkinson’s disease characterized by alpha-synuclein overexpression in the song-dedicated anterior forebrain pathway;PLOS ONE;2022-05-04